Ticker name:MDGLMADRIGAL PHARMACEUTICALS, INC.
Country: US-Sector: Healthcare, Industry: Biotechnology
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for managing non-alcoholic steatohepatitis (NASH). The company's pipeline also features MGL-3745, which serves as a secondary or backup compound to resmetirom. Madrigal holds a collaborative agreement with Hoffmann-La Roche, encompassing research, development, and commercialization activities. The company's operations are based out of West Conshohocken, Pennsylvania.
- CEO: William J. Sibold
- IPO: Feb 06, 2007
- Website:...igalpharma.com (open a new tab)
Market Cap 9.8B
Last close 423.96$
Key metrics
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 136B | 537.79$ | |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 99B | 952.4$ | |
| 3 | MRNA | Moderna, Inc. | 87B | 215.27$ | |
| 4 | RVMD | Revolution Medicines, Inc. | 36B | 166.87$ | |
| 5 | GMAB | GENMAB A/S | 32B | 51.57$ | |
| 6 | ROIV | Roivant Sciences Ltd. | 28B | 38.61$ | |
| 7 | INSM | INSMED Inc | 27B | 122.88$ | |
| 8 | UTHR | UNITED THERAPEUTICS Corp | 25B | 587.88$ | |
| 9 | INCY | INCYTE CORP | 25B | 120.27$ | |
| 10 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 21B | 159.73$ | |
| 11 | ASND | Ascendis Pharma A/S | 18B | 271.73$ | |
| 12 | NBIX | NEUROCRINE BIOSCIENCES INC | 17B | 165.31$ | |
| 13 | EXEL | EXELIXIS, INC. | 16B | 67.1$ | |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15B | 239.77$ | |
| 15 | BBIO | BridgeBio Pharma, Inc. | 15B | 77.36$ | |
| 16 | TECH | BIO-TECHNE Corp | 11B | 72.79$ | |
| 17 | BMRN | BIOMARIN PHARMACEUTICAL INC | 11B | 57.99$ | |
| 18 | HALO | HALOZYME THERAPEUTICS, INC. | 11B | 96.5$ | |
| 19 | KYMR | Kymera Therapeutics, Inc. | 11B | 125.85$ | |
| 20 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 9.8B | 423.96$ |